Health & Fitness:Medicine
Antisense Therapeutics is bringing bringing life changing innovative medicines to patients with rare diseases
Mark Diamond, Managing Director and CEO at Antisense Therapeutics Limited joins eHealth Radio and the Health News Channel. Antisense is an Australian publicly-listed biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases.
Listen to host Eric Dye & guest Mark Diamond discuss the following:
Mark Diamond has over 30 years experience in the pharmaceutical and biotechnology industry. Before joining Antisense Therapeutics Limited as MD and CEO in 2001, Mr. Diamond was employed in the US as Director, Project Planning/Business Development at Faulding Pharmaceuticals. Prior to this he held the positions of Senior Manager, Business Development and In-licensing within Faulding’s European operation based in the UK and International Business Development Manager with Faulding in Australia.
Social Media Links:
People also listened to this: How to Battle Snoring with The Snorinator
It is Free
Copyright © 2006-2023 Podbean.com